CHELMSFORD, MASSACHUSETTS / ACCESS Newswire / January 28, 2025 / Harte Hanks, Inc. (NASDAQ:HHS), a pioneer in data-driven customer experience solutions that has been transforming how companies connect with their customers for over 100 years, announced today a strategic leadership transition. Kirk Davis, the company’s Chief Executive Officer, has decided to step down for personal […]
RTX exceeds 2024 sales and EPS expectations*; Expects continued sales, earnings, and cash flow growth in 2025 RTX (NYSE: RTX) reports fourth quarter 2024 results and announces 2025 outlook. Fourth quarter 2024 — Sales of $21.6 billion, up 9 percent versus prior year, and up 11 percent organically* excluding divestitures — GAAP EPS was $1.10
Today, Cyngn (Nasdaq: CYN) announced that it will be deploying its DriveMod Tuggerat a major Consumer Packaged Goods (CPG) distribution company. This deployment reaffirms Cyngn's expanding presence across manufacturing and distribution, highlighting the versatility of its Enterprise Autonomy Suite (“EAS”). This news comes just after Cyngn's recent contractwith a separate company in the automotive manufacturing
The Liaoning TV Spring Festival Gala has long been a spectacular showcase of audiovisual artistry. Each year, this grand event captivates both national and global audiences, presenting a formidable challenge to choreographers tasked with crafting performances that are not only dazzling but also deeply rooted in cultural significance. Balancing the dual demands of entertainment and
(NasdaqGM:CLSD), – Upcoming Presentations at Angiogenesis and Macula Society Conferences to Feature CLS-AX Sub-Group Analyses from ODYSSEY Wet AMD Trial – – CLS-AX Targets Flexible Dosing of Biologics with Duration of Tyrosine Kinase Inhibitors – ALPHARETTA, Ga., Jan. 28, 2025 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of
Topical LUT014 Treats EGFRi (Epidermal Growth Factor Receptor Inhibitor) Induced Acneiform Rash, Potentially Improving The Treatment's Efficacy And Patients' Quality of Life Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous dose-limiting toxicity, today announced that it has secured a $30 million financing to advance the development of LUT014,
Interplay Learning, the leader in immersive learning for the skilled trades, proudly announces the launch of its new industrial maintenance catalog. Designed to meet the evolving needs of industrial operations, this growing catalog offers a wide range of expert-led courses and hands-on 3D simulations to enhance workforce performance and operational efficiency. https://mma.prnewswire.com/media/2607340/Downtime_Dilemma.jpg Interplay's industrial maintenance
NEW YORK, NY / ACCESS Newswire / January 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Innovative Industrial Properties, Inc. ("IIPR" or "the Company") (NYSE:IIPR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against
NEW YORK CITY, NY / ACCESS Newswire / January 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Capri Holdings Limited ("Capri" or "the Company") (NYSE:CPRI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against
NEW YORK CITY, NY / ACCESS Newswire / January 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. ("Cassava" or "the Company") (NASDAQ:SAVA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against